Parkman Healthcare Partners LLC

Position in ANNX — Annexon, Inc.

CIK 1777015 STAMFORD, CT

Position in ANNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,734,032

+$715,998 QoQ

Shares Held

674,013

+12.1% QoQ

Ownership

0.338%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Parkman Healthcare Partners LLC holds $362,342,788 across 36 Biotechnology names. ANNX ranks #29 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KALV	KalVista Pharmaceuticals, Inc.	1,835,506	$36,948,735
2	PTCT	Ptc Therapeutics, Inc.	431,364	$29,388,829
3	XENE	Xenon Pharmaceuticals Inc.	497,035	$28,902,585
4	RCUS	Arcus Biosciences, Inc.	1,207,274	$26,077,118
5	MBX	MBX Biosciences, Inc.	800,037	$23,881,104
6	SNDX	Syndax Pharmaceuticals Inc	901,511	$21,059,296
7	EYPT	EyePoint, Inc.	1,354,800	$17,463,372
8	AGIO	Agios Pharmaceuticals, Inc.	403,525	$13,651,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,734,032	674,013	+12.1%	Shares	Sole	2026-05-15
2025-12-31	$3,018,034	601,202	+48.1%	Shares	Sole	2026-02-17
2025-09-30	$1,238,156	405,953	+0.4%	Shares	Sole	2025-11-14
2025-06-30	$970,065	404,194	+15.0%	Shares	Sole	2025-08-14
2025-03-31	$678,271	351,436	+6.2%	Shares	Sole	2025-05-15
2024-12-31	$1,697,255	330,849	+0.7%	Shares	Sole	2025-02-14
2024-09-30	$1,945,388	328,613	+0.5%	Shares	Sole	2024-11-14
2024-06-30	$1,601,540	326,845	-5.7%	Shares	Sole	2024-08-14
2024-03-31	$2,485,745	346,687	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.